Stem Cells as an Emerging Paradigm in Stroke 4-Reference-Cited by-同舟云学术

Stem Cells as an Emerging Paradigm in Stroke 4

Published:2019-11 Issue:11 Volume:50 Page:3299-3306
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Boltze Johannes¹,Modo Michel M.²³,Mays Robert W.⁴,Taguchi Akihiko⁵,Jolkkonen Jukka⁶⁷⁸,Savitz Sean I.⁹,Bates Damien,Bath Philip,Carmichael Stanley Thomas,Cox Charles S.,Daadi Marcel M.,Tejedor Euperio Diez,Grande Andrew W.,Gutiérrez-Fernández María,Hematti Peiman,Hess David,Huang David Y.,Kokaia Zaal,Kuroda Satoshi,Moniche Francisco P.,Muir Keith,Olson Scott,de Castro Paulo Henrique Rosado,Sinden John,Satani Nikunj,Shichinohe Hideo,Steinberg Gary K.,Walczak Piotr,Wechsler Lawrence,West Franklin,Vahidy Farhaan,Vawter Dorothy E.,Yavagal Dileep R.,Yang Bing,Zrinzo Ludvic,

Affiliation:

1. From the School of Life Sciences, University of Warwick, Coventry, United Kingdom (J.B.)

2. Departments of Radiology (M.M.M.), McGowan Institute for Regenerative Medicine, University of Pittsburgh, PA

3. Bioengineering (M.M.M.), McGowan Institute for Regenerative Medicine, University of Pittsburgh, PA

4. Department of Neurosciences, Athersys, Inc, Cleveland, OH (R.W.M.)

5. Department of Regenerative Medicine, Institute for Biomedical Research and Innovation, Kobe, Japan (A.T.)

6. Institute of Clinical Medicine-Neurology, University of Eastern Finland, Kuopio, Finland (J.J.)

7. Neurocenter, Kuopio University Hospital, Finland (J.J.)

8. A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland (J.J.)

9. Institute for Stroke and Cerebrovascular Disease, UTHealth, Houston, TX (S.I.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference59 articles.

1. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study [published online November 23, 2018].;Steinberg GK;J Neurosurg

2. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial

3. Increasing dose of autologous bone marrow mononuclear cells transplantation is related to stroke outcome: results from a pooled analysis of two clinical trials.;Moniche F;Stem Cells Int,2016

4. Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study

5. Stem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?;Sandu RE;Exp Gerontol,2017

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities for developing neural stem cell treatments for acute ischemic stroke: A systematic review and gap analysis;Journal of Clinical Neuroscience;2024-02

2. NCAM mimetic peptide P2 synergizes with bone marrow mesenchymal stem cells in promoting functional recovery after stroke;Journal of Cerebral Blood Flow & Metabolism;2024-01-17

3. Recent advances in tissue repair of the blood-brain barrier after stroke;Journal of Tissue Engineering;2024-01

4. Beneath the radar: immune-evasive cell sources for stroke therapy;Trends in Molecular Medicine;2024-01

5. The potential of a combined cell‐based therapy and rehabilitation approach for stroke recovery;Neuroprotection;2023-12